✦ LIBER ✦

Is the increase in orchiectomy for prostate cancer patients appropriate?

✍ Scribed by Gerald W. Chodak

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 37 KB
Volume: 112
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23417

No coin nor oath required. For personal study only.

✦ Synopsis

An increase in the use of bilateral orchiectomy has been observed coinciding with a decrease in the use of lutenizing hormone‐releasing hormone therapy for men who require castration for their prostate cancer. This finding has raised 2 questions: 1) is this good or bad for patients? and 2) are economic factors driving this decision? Currently, it is not possible to conclude that patient care is being compromised without knowing more regarding the clinical factors resulting in this change; however, compromised care is 1 possibility. The other question also cannot be answered; however, changes in reimbursement may contribute partially to this change. Regardless of the reason, the author believes that optimal care of patients dictates an honest and open discussion of the pros and cons for the various options available for castration.

📜 SIMILAR VOLUMES

A comparison of diethylstilbestrol or or

A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate

✍ R. P. Huben; G. P. Murphy; The Investigators of the National Prostatic Cancer Pr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

Is there a role for platinum chemotherap

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

✍ William K. Oh; Miah-Hiang Tay; Jiaoti Huang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

Chemotherapy for hormone-refractory pros

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

✍ Tomasz Beer; Derek Raghavan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Observations on the doubling time of pro

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

✍ Hans-Peter Schmid; John E. McNeal; Thomas A. Stamey 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB

PSCA mRNA expression in preoperatively n

PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia

✍ Zhigang Zhao; Wenjing Ma; Guohua Zeng; Defeng Qi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

The National Cancer Data Base Report on

The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.

✍ Curtis J. Mettlin; Gerald P. Murphy; Charles J. McDonald; Herman R. Menck 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

BACKGROUND. An increase in the proportion of prostate carcinomas diagnosed at early, potentially curable stages has led to several changes in treatment of patients with this disease. Greater use of radical prostatectomy and external beam radiation has been documented, and recent data suggest that th